Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability

Por Bandinelli, Francesca, Scazzariello, Francesco, Pimenta da Fonseca, Emanuela, Barreto Santiago, Mittermayer, Marcassa, Claudio, Nacci, Francesca, Matucci Cerinic, Marco
Publicado no Drug Des Devel Ther (2016)

Identification of PPARγ ligands with One-dimensional Drug Profile Matching

Por Kovács, Diána, Simon, Zoltán, Hári, Péter, Málnási-Csizmadia, András, Hegedűs, Csaba, Drimba, László, Németh, József, Sári, Réka, Szilvássy, Zoltán, Peitl, Barna
Publicado em 2013

Deposition and transport of linezolid mediated by a synthetic surfactant Synsurf(®) within a pressurized metered dose inhaler: a Calu-3 model

Por van Rensburg, Lyné, van Zyl, Johann M, Smith, Johan
Publicado no Drug Des Devel Ther (2018)

Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies

Por Suba, Zsuzsanna
Publicado em 2014

D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis

Por Xia, Jing, Du, Yanqiu, Han, Jiyang, Liu, Guo, Wang, Xumei
Publicado no Drug Des Devel Ther (2015)

Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state

Por Jang, Kyungho, Yoon, Seonghae, Kim, Sung-Eun, Cho, Joo-Youn, Yoon, Seo Hyun, Lim, Kyoung Soo, Yu, Kyung-Sang, Jang, In-Jin, Lee, Howard
Publicado em 2014

New developments in the management of partial-onset epilepsy: role of brivaracetam

Por Coppola, Giangennaro, Iapadre, Giulia, Operto, Francesca Felicia, Verrotti, Alberto
Publicado no Drug Des Devel Ther (2017)

Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent

Por Rickardson, Linda, Kutvonen, Emma, Orasniemi, Satu, Högberg, Marita, Kallio, Marko J, Rehnmark, Stefan
Publicado no Drug Des Devel Ther (2017)

Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran

Por Leung, Timothy S, Law, Ernest H
Publicado no Drug Des Devel Ther (2015)

Effect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide

Por Jiang, Jinfang, Pang, Xuehai, Li, Liang, Dai, Xiaojian, Diao, Xingxing, Chen, Xiaoyan, Zhong, Dafang, Wang, Yingwei, Chen, Yuanwei
Publicado no Drug Des Devel Ther (2016)

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of...

Por Palumbo, Raffaella, Sottotetti, Federico, Trifirò, Giuseppe, Piazza, Elena, Ferzi, Antonella, Gambaro, Anna, Spinapolice, Elena Giulia, Pozzi, Emma, Tagliaferri, Barbara, Teragni, Cristina, Bernardo, Antonio
Publicado no Drug Des Devel Ther (2015)

BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo

Por Kalanaky, Somayeh, Hafizi, Maryam, Fakharzadeh, Saideh, Vasei, Mohammad, Langroudi, Ladan, Janzamin, Ehsan, Hashemi, Seyed Mahmoud, Khayamzadeh, Maryam, Soleimani, Masoud, Akbari, Mohammad Esmaeil, Nazaran, Mohammad Hassan
Publicado no Drug Des Devel Ther (2015)

New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant pat...

Por Kim, Yu Kyong, Kim, Anhye, Park, Shin Jung, Lee, Howard
Publicado no Drug Des Devel Ther (2017)